News about Drug Discovery & Development

Sun Pharma to Invest Rs 500 Crore in Expansion of Assam Manufacturing Unit

Sun Pharmaceutical Industries said it will invest Rs 500 crore to expand its manufacturing facility in Assam, aiming to strengthen its domestic production infrastructure and support future growth.

Drug Discovery & Development | 06/02/2026 | By Darshana |  178

Lupin Launches Dasatinib Tablets in USA Following FDA Approval

Lupin Limited has announced the launch of dasatinib tablets in multiple strengths in the United States following approval of its Abbreviated New Drug Application from the USA Food and Drug Administration.

Drug Discovery & Development | 03/02/2026 | By Darshana |  162

Frontage Labs Expands Early-Phase Clinical Capabilities for Global Drug Development

Frontage's US operations are anchored by a modern 160?bed, 36,000?sq?ft phase-I clinical unit in Secaucus, New Jersey, designed to conduct large?scale phase-I and bioequivalence (BE) studies as well as radiolabeled human AME research.

Drug Discovery & Development | 31/01/2026 | By News Bureau

NanoMosaic Secures FDA AMT Designation for Nanoneedle Technology in AAV Gene Therapy Manufacturing

FDA’s CBER grants Advanced Manufacturing Technology designation to NanoMosaic’s Nanoneedle platform, enhancing regulatory engagement and streamlining quality control in AAV gene therapy production.

Drug Discovery & Development | 30/01/2026 | By News Bureau |  121

Grail Submits Final PMA Module to FDA for Galleri Multi-Cancer Early Detection Test

Grail files the final Premarket Approval module with the FDA for its Breakthrough Device-designated Galleri test, supported by data from over 25,000 participants in PATHFINDER 2 and the NHS-Galleri trial.

Drug Discovery & Development | 30/01/2026 | By News Bureau |  422

European Commission Expands Bracco's Vueway Approval to Infants and Neonates

Bracco Imaging secures EU approval to extend Vueway’s use to infants and neonates, enhancing safe and effective MRI diagnostics for young patients.

Drug Discovery & Development | 28/01/2026 | By News Bureau |  120

European Commission Expands GSK's RSV Vaccine Arexvy to Adults Aged 18 and Above

GSK’s RSV vaccine Arexvy receives European approval for adults aged 18 plus, marking a major expansion in protection against RSV-related respiratory illness across the region.

Drug Discovery & Development | 28/01/2026 | By News Bureau |  121

FDA Clears Expanded Access Programme for StemCyte's RegeneCyte Therapy in Long covid Patients

The FDA has approved an Expanded Access programme for StemCyte’s RegeneCyte, enabling eligible Long covid patients to access the cord blood-based therapy amid ongoing clinical trials.

Drug Discovery & Development | 27/01/2026 | By News Bureau |  270

ACON Launches FDA-Cleared Flowflex Plus 4-in-1 Home Test for RSV, Flu and Covid, Including Infants

Acon Laboratories has launched the first FDA-cleared 4-in-1 home test detecting RSV, Flu A, Flu B and Covid-19, approved for adults and children as young as six months.

Drug Discovery & Development | 27/01/2026 | By News Bureau |  253

BD Launches Research Cloud 7.0 With AI-Powered Horizon Panel Maker to Advance Flow Cytometry Research

BD has launched Research Cloud 7.0 globally, introducing the AI-driven Horizon Panel Maker to automate panel design, streamline workflows and enhance data quality in immunology and cancer research.

Drug Discovery & Development | 27/01/2026 | By News Bureau |  261